EFS
CGTX icon

Essex Financial Services’s Cognition Therapeutics CGTX Stock Holding History

Essex Financial Services’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Hold
40,000
– – ﹤0.01% 831
2026
Q1 		$30.4K Buy
40,000
+20,000
+100% +$23.3K ﹤0.01% 791
2025
Q4 		$27K Buy
+20,000
New +$32.5K ﹤0.01% 784
2025
Q3 		– Sell
-39,595
Closed -$12.3K – 752
2025
Q2 		$12.3K Hold
39,595
– – ﹤0.01% 688
2025
Q1 		$16.7K Buy
+39,595
New +$23.3K ﹤0.01% 631

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Essex Financial Services's CGTX Position: Q2 2026 in Review

Essex Financial Services held its Cognition Therapeutics (CGTX) position steady in Q2 2026 at 40,000 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #831.

Essex Financial Services first reported a position in CGTX in Q1 2025 and has held it in 5 quarters since. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Essex Financial Services held 40,000 shares of Cognition Therapeutics worth $46K as of Q2 2026.
  • Essex Financial Services left its Cognition Therapeutics share count unchanged in Q2 2026.
  • Cognition Therapeutics made up ﹤0.01% of Essex Financial Services's portfolio in Q2 2026, its #831 holding.
  • Essex Financial Services first reported a position in Cognition Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Essex Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.